Michael E. Burczynski

5.9k citations
62 papers · 5k · 2 hit papers · h-index 32

Impact in

Papers in

    • Pharmacogenetics and Drug Metabolism 19
    • Bioactive Compounds and Antitumor Agents 7

Michael E. Burczynski

60 papers receiving 4.8k citations

Michael E. Burczynski's Hit Papers

Discovery and validation of biomarkers to aid the development of safe and effective pain therapeutics: challenges and opportunities 2020 · 349 citations
3490+9+18Years since publication100200300400

Peers

Michael E. Burczynski
Comparison fields: 5 of 144
  • Pharmacology 543
  • Cancer Research 691
  • Health, Toxicology and Mutagenesis 451
  • Toxicology 169
  • Cell Biology 415
Replace John L. Farber with:
John L. Farber United States
Ryuichi Kato Japan
Paul Nioi United States
Agapios Sachinidis Germany
Frederick E. Domann United States
Susan M. Fischer United States
Yvonne Will United States
Gábor Bánhegyi Hungary
Julie F. Foley United States
Shigeru Sassa United States
Michael E. Burczynski relative to John L. Farber United States John L. Farber's profile →
Citations per field
00.5×1.5×2×2.3×
John L. Farber · 1×
Citations per year

Countries citing papers authored by Michael E. Burczynski

Since Specialization
Citations

This map shows the geographic impact of Michael E. Burczynski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Burczynski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Burczynski more than expected).

Fields of papers citing papers by Michael E. Burczynski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael E. Burczynski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Burczynski. The network helps show where Michael E. Burczynski may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael E. Burczynski, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael E. Burczynski Line = papers co-authored together Michael E. Burczynski links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 62 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2000571
2 2011410
3
Dihydrodiol Dehydrogenases and Polycyclic Aromatic Hydrocarbon Activation: Generation of Reactive and Redox Active o-Quinones
Hit paper breakdown →
1998407
4
Discovery and validation of biomarkers to aid the development of safe and effective pain therapeutics: challenges and opportunities
Hit paper breakdown →
2020349
5 2006208
6 2000192
7
Isoform-specific induction of a human aldo-keto reductase by polycyclic aromatic hydrocarbons (PAHs), electrophiles, and oxidative stress: implications for the alternative pathway of PAH activation catalyzed by human dihydrodiol dehydrogenase.
1999180
8 2012175
9 2001172
10 2009170
11 2009137
12 2006127
13 1998125
14
Disease-associated expression profiles in peripheral blood mononuclear cells from patients with advanced renal cell carcinoma.
2003124
15
Genotoxic polycyclic aromatic hydrocarbon ortho-quinones generated by aldo-keto reductases induce CYP1A1 via nuclear translocation of the aryl hydrocarbon receptor.
2000123
16 2001108
17 2005107
18 2009100
19 200197
20 202196

About Michael E. Burczynski

Michael E. Burczynski is a scholar working on Pharmacology, Toxicology, Cancer Research, Cell Biology and Molecular Biology, having authored 62 papers that have together received 5k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (19 papers), Gene expression and cancer classification (10 papers), Aldose Reductase and Taurine (8 papers), Bioactive Compounds and Antitumor Agents (7 papers), Renal cell carcinoma treatment (4 papers), Alzheimer's disease research and treatments (3 papers), Carcinogens and Genotoxicity Assessment (3 papers) and Liver Disease Diagnosis and Treatment (3 papers). The work is most often cited by research in Pharmacology (543 citations), Cancer Research (691 citations), Health, Toxicology and Mutagenesis (451 citations), Toxicology (169 citations) and Cell Biology (415 citations). Michael E. Burczynski has collaborated with scholars based in United States, United Kingdom and Türkiye. Frequent co-authors include T.M. Penning, Nisha T. Palackal, Saumya Pant, Holly Hilton, Chien‐Fu Hung, Andrew J. Dorner, Ronald G. Harvey, Joseph M. Jez, Haiching Ma and Kapila Ratnam. Their work appears in journals such as Biochemistry, iScience, The Lancet, Molecular and Cellular Endocrinology and Alzheimer s & Dementia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact